Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA® Media ReleaseCarolyn MillerJanuary 12, 2021Clinical Genomics, Paul Kelly
Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer) Media ReleaseCarolyn MillerNovember 16, 2020Clinical Genomics, Paul Kelly
Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA® Media ReleaseCarolyn MillerMay 27, 2020Clinical Genomics, Paul Kelly
Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test Media ReleaseCarolyn MillerApril 30, 2020Clinical Genomics, Paul Kelly
Clinical Genomics’ gene-based blood test Colvera a first The AustralianCarolyn MillerJune 1, 2018Clinical Genomics, Paul Kelly
Clinical Genomics hits a milestone in colon cancer prevention AnnouncementCarolyn MillerAugust 30, 2017Clinical Genomics, Paul Kelly
Clinical Genomics Strenghtens it's Leadership Team with Multiple Key Appointments Media ReleaseCarolyn MillerOctober 19, 2016Clinical Genomics, Paul Kelly
Data published in Cancer Medicine Demostrate Clinical Genomics' Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test Media ReleaseCarolyn MillerOctober 19, 2016Clinical Genomics, Paul Kelly
$20m in financing for blood-based bowel cancer test LabOnlineCarolyn MillerMarch 23, 2016Clinical Genomics, Paul Kelly
Clinical Genomics brings home $15M for two-gene colorectal cancer test Fierce BiotechCarolyn MillerMarch 23, 2016Clinical Genomics, OneVentures, Paul Kelly
Biotech company Clinical Genomics raises US$15 million round led by OneVentures Startup DailyCarolyn MillerMarch 23, 2016Clinical Genomics, Paul Kelly
